Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+54.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+54.1%/yr
vs +123.5%/yr prior
Acceleration
-69.4pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
3.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.68M | +26.4% |
| 2024 | $2.12M | +65.0% |
| 2023 | $1.28M | +75.5% |
| 2022 | $731000.00 | +960.0% |
| 2021 | $-85000.00 | +97.4% |
| 2020 | $-3.22M | -12658.5% |
| 2019 | $25648.00 | -12.5% |
| 2018 | $29299.00 | +103.1% |
| 2017 | $-935125.00 | -206.2% |
| 2016 | $880735.00 | - |